Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for Initiation of a Global Phase 2 Trial for TransCon CNP in Children with Achondroplasia

0
13

Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for Initiation of a Global Phase 2 Trial for TransCon CNP in Children with Achondroplasia

LEAVE A REPLY

Please enter your comment!
Please enter your name here